Accessibility Menu
iShares Trust - iShares Biotechnology ETF logo

iShares Trust - iShares Biotechnology ETF(NASDAQ) IBB

Current Price$188.35
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)+478%
5 Year+15%
1 Year+44%
1 Month+7%
iShares Trust - iShares Biotechnology ETF last closing stock price
MetricPriceDate
Last closeUSD 186.532026-07-20
iShares Trust - iShares Biotechnology ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.59%USD 189.552026-07-13
1 month+7.42%USD 173.642026-06-18
3 month+7.22%USD 173.972026-04-21
Year to date+10.62%USD 168.622025-12-31
1 year+44.15%USD 129.402025-07-18
3 year+43.07%USD 130.372023-07-21
5 year+14.67%USD 162.672021-07-21
Since inception+477.53%USD 32.302001-02-09

iShares Trust - iShares Biotechnology ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.41

Beta (Volatility)

0.86 (Low)

Price

$188.35

Volume

459,213.465

Open

$186.24

Previous Close

$186.53

Daily Range

$185.59 - $189.39

52-Week Range

$129.85 - $199.05

Estimated Earnings Date

N/A

IBB News

ETFvsETF-Purple.png

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

Jake LerchJul 12, 2026
A scientist looking through a microscope.

5 Best Biotech ETFs for 2026 and How to Invest

Keith SpeightsJul 10, 2026
ETFvsETF-Red.png

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

Andy GouldJul 10, 2026
ETFvsETF-Blue.png

Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?

Erin KennedyJul 4, 2026
ETFvsETF-Purple.png

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

Erin KennedyJul 2, 2026
SellAlert-Blue.png

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

Eric TrieMar 21, 2026
A biotech lab technician using multiple pipettes to load blood samples into test tubes.

How to Invest in iShares Biotechnology ETF (IBB)

Tony DongFeb 25, 2026
DNA with a healthcare professional in the background pointing to a lighted section of a DNA strand.

How to Buy Moderna Stock (MRNA) in 2026

Rachel WarrenFeb 18, 2026
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iShares Trust - iShares Biotechnology ETF

The iShares Biotechnology ETF is designed to mirror the investment performance of a specific market index comprising publicly traded stocks in the U.S. biotechnology sector. This ETF offers investors exposure to a diverse range of biotechnology companies, making it a compelling option for those interested in this dynamic industry.

Products and Services
  • Tracks the performance of biotechnology companies in the U.S.
  • Provides investors with diversified exposure to the biotech sector
  • Offers a low-cost investment option through an exchange-traded fund structure
Growth Outlook
  • Biotechnology sector projected to grow significantly over the next decade
  • Increased demand for innovative therapies drives industry expansion
  • Technological advancements enhance research and development capabilities
Financial Highlights
  • Market capitalization of approximately $9.38 billion
  • Recent stock price range between $128.84 and $199.05
  • Trailing twelve-month dividend yield of 0.22%
The iShares Biotechnology ETF provides a strategic investment opportunity in a sector characterized by rapid growth and innovation. With a market capitalization of around $9.38 billion, the ETF reflects the robust performance of biotechnology companies. The recent stock price range indicates a healthy trading environment, while the trailing twelve-month dividend yield of 0.22% offers a modest return for investors. The growth outlook for the biotechnology sector remains strong, driven by increasing demand for innovative therapies and advancements in technology. This ETF serves as a valuable tool for investors looking to capitalize on the potential of the biotechnology industry.
AI Generated • Jul 19, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

San Francisco, CA 94105, US

IBB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.22%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

49.50M

Volume

459.21K

Avg. Volume

1.57M

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

iShares Trust - iShares Biotechnology ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IJTiShares S&P Small-Cap 600 Growth ETF
$173.81+1.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$11.93-0.02%
NOKNokia
$10.72+0.06%
UTZUtz Brands
$14.10+0.89%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$35.50+0.25%

Questions About IBB

What is the current price of iShares Trust - iShares Biotechnology ETF?

iShares Trust - iShares Biotechnology ETF is trading at $188.26 per share.

What is the 52-week range for iShares Trust - iShares Biotechnology ETF?

Over the past 52 weeks, iShares Trust - iShares Biotechnology ETF has traded between $129.85 and $199.05.

How much debt does iShares Trust - iShares Biotechnology ETF have?

iShares Trust - iShares Biotechnology ETF total debt is unavailable.

How much cash does iShares Trust - iShares Biotechnology ETF have on hand?

iShares Trust - iShares Biotechnology ETF does not have cash on hand data available.

What is iShares Trust - iShares Biotechnology ETF’s dividend yield?

iShares Trust - iShares Biotechnology ETF currently has a dividend yield of 0.22%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services